Expedia Group Vs. Bright Minds Biosciences Industry Stock Comparison

Buy

80

EXPE
Expedia Group

Last Price:

$186.08

Seasonality Move:

3.15%

Sell

45

DRUG
Bright Minds Biosciences

Last Price:

$39.35

Seasonality Move:

-32.13%

Buy

80

Expedia Group (EXPE) is a Buy

Is Expedia Group a Buy, Sell or Hold?

The current Expedia Group [EXPE] share price is $186.09. The Score for EXPE is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
EXPE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

45

Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

The current Bright Minds Biosciences [DRUG] share price is $39.85. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EXPE Stock Price Chart

What is Expedia Group's stock price today?

The Expedia Group share price today is $186.09

The current trend is moderately bullish and EXPE is experiencing slight buying pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

The Bright Minds Biosciences share price today is $39.85

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

EXPE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.88	Buy
Relative Strength Index (14 RSI):	54.46	Buy
Chaikin Money Flow:	254118	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(182.24 - 189.5)	Buy
Bollinger Bands (100):	(140 - 181.56)	Buy

DRUG Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.04	Buy
Relative Strength Index (14 RSI):	51.96	Buy
Chaikin Money Flow:	6916	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(37.23 - 42.31)	Buy
Bollinger Bands (100):	(3.23 - 44.21)	Buy

EXPE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	187.37	Sell
20-day SMA:	186.01	Buy
50-day SMA:	179.12	Buy
200-day SMA:	143.05	Buy
8-day EMA:	186.1	Sell
20-day EMA:	185.07	Buy
50-day EMA:	177.69	Buy
200-day EMA:	151.38	Buy

DRUG Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	38.78	Buy
20-day SMA:	38.81	Buy
50-day SMA:	41.79	Sell
200-day SMA:	12.42	Buy
8-day EMA:	39	Buy
20-day EMA:	39.09	Buy
50-day EMA:	36.04	Buy
200-day EMA:	18.43	Buy

Expedia Group Earnings Growth & EXPE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.28 per share, and an increase next year of $2.81 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Expedia Group Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31	Jan 2	Jan 3
	Dec									Jan
	19	20	23	24	26	27	30	31	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):